Jula Inrig
Chief Medical Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Travere Therapeutics, Inc. (TVTX) | Chief Medical Officer | $568,084 | $3,041,632 |
| 2024 | Travere Therapeutics, Inc. (TVTX) | Chief Medical Officer | $522,083 | $1,681,277 |
| 2023 | Travere Therapeutics, Inc. (TVTX) | Chief Medical Officer | $486,250 | $2,001,539 |
| 2022 | Travere Therapeutics, Inc. (TVTX) | Chief Medical Officer | $445,000 | $2,866,793 |
Earnings-call appearances
-
Travere Therapeutics FDA Approval of FILSPARI in FSGS Conference Call2026-04-13
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q4 FY2025 Earnings Call2026-02-19
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q3 FY2025 Earnings Call2025-10-30
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q2 FY2025 Earnings Call2025-08-06
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q1 FY2025 Earnings Call2025-05-01
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q4 FY2024 Earnings Call2025-02-20
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q3 FY2024 Earnings Call2024-10-31
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q2 FY2024 Earnings Call2024-08-01
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-06
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q4 FY2023 Earnings Call2024-02-15
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q3 FY2023 Earnings Call2023-11-07
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-03
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q1 FY2023 Earnings Call2023-05-04
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q4 FY2022 Earnings Call2023-01-09
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q3 FY2022 Earnings Call2022-10-27
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-04
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-05
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q4 FY2021 Earnings Call2022-01-10
Travere Therapeutics, Inc. (TVTX)